Full Press Release Details
IDEAYA Biosciences Appoints Daniel A Simon as Chief Business Officer to Lead Corporate Strategy and Business Development.
IDYA
IDEAYA Biosciences Appoints Daniel A Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
Key Takeaway: IDEAYA Biosciences Appoints Daniel A Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
Price reaction · baseline $37.71 (2024-05-24 close) · hit after-hours · 3 other IDYA headline(s) in the window, move may be shared
day 0 close
-0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma